FDA MAPP 5223.6 Assessment of User Interface of Drug-Device Combination Product Submitted in Pre-ANDA Communication or ANDA, 06/22 Beatrice Burtsov2022-09-07T07:14:58+00:00September 7th, 2022| About the Author: Beatrice Burtsov